Skip to main content
. Author manuscript; available in PMC: 2009 Sep 14.
Published in final edited form as: Arch Neurol. 2008 Dec;65(12):1621–1628. doi: 10.1001/archneur.65.12.1621

Table 3.

Likelihood Ratio Tests Evaluating the Additive Effect of Each of 2 Predictors Given That the Other Predictor Is in the Model After Adjusting for Age, Sex, and Education

Predictor 1 Predictor 2 Additive Effect (P Value)

Predictor 1 Predictor 2


All Groupsa MCI Onlyb All Groupsa MCI Onlyb
Hippocampal W score NAA:Cr ratio 54 (<.001) 14 (.001) 7.4 (.06) 1.6 (.46)
mI:Cr ratio 50 (<.001) 14 (.001) 18 (<.001) 14 (.001)
Cho:Cr ratio 52 (<.001) 15 (<.001) 11 (.01) 3.6 (.16)
Log(WMH volume) 54 (<.001) 15 (<.001) 18 (<.001) 5.4 (.07)
Cortical infarctionsc 13 (.002) 1.5 (.47)
NAA:Cr ratio mI:Cr ratio 4.7 (.20) 2.4 (.31) 19 (<.001) 15 (<.001)
Cho:Cr ratio 7.7 (.053) 1.5 (.46) 13 (.005) 2.6 (.27)
Log(WMH volume) 5.2 (.16) 1.8 (.42) 16 (.001) 4.8 (.09)
Cortical infarctionsc 1.7 (.43) 2.7 (.26)
mI:Cr ratio Cho:Cr ratio 14 (.003) 13 (.002) 7.2 (.07) 0.74 (.69)
Log(WMH volume) 21 (<.001) 16 (<.001) 18 (<.001) 5.7 (.06)
Cortical infarctionsc 13 (.001) 1.2 (.56)
Cho:Cr ratio Log(WMH volume) 9.0 (.03) 2.5 (.28) 14 (.002) 4.6 (.10)
Cortical infarctionsc 2.4 (.30) 2.3 (.31)
Log(WMH volume) Cortical infarctionsc 5.2 (.07) 3.1 (.21)

Abbreviations: Cho, choline; Cr, creatine; mI, myo-inositol; MCI, mild cognitive impairment; NAA, N-acetylaspartate; WMH, white matter hyperintensity; ellipses not reported.

a

Based on a 3-df χ2 test.

b

Based on a 2-df χ2 test.

c

Because absence of cortical infarctions was among the inclusion criteria for the cognitively normal group, the results among all 4 groups are not reported